RaySearch Laboratories AB (publ) RAY.B
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow RaySearch Laboratories AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
Stockholm
Type
Technology
Sector
Medical software for cancer treatment
Price & valuation
Last close
SEK 192
1 week
+10.4 %
3 months
+6.0 %
12 months
-32.2 %
From 52w high
-36.1 %
From 52w low
+16.5 %
We're already tracking RaySearch Laboratories AB (publ) — here are the latest events we've registered
Recent News
- On June 5, 2026, the company announced it would showcase new advances in particle therapy at the PTCOG 64 conference. Highlights include improved support for reirradiation in the upcoming version of the RayStation treatment planning system.
What Firelda Watch includes for RaySearch Laboratories AB (publ)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of RaySearch Laboratories AB (publ) will be delivered in the same format.
Want to follow RaySearch Laboratories AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.